A theoretical investigation of the supersaturation of basic calcium phosphate in serum of dialysis patients

Journal of Applied Biomaterials and Biomechanics

Volumn 4, Issue 2, 2006, Pages 80-86

  Sandin, K ^a,b   Hegbrant, J ^a   Kloo, Lars ^b   Olsson, L F ^a  

^a Gambro AB   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Biomineralization; Brushite; Calcification; Calcium phosphate; Hyperphosphatemia

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; HYDROXYAPATITE; PHOSPHATE;

BIOMINERALIZATION; CALCIFICATION; CALCIUM BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; PHOSPHATE BLOOD LEVEL; REVIEW;

EID: 33749648142     PISSN: 17226899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Foley R, Parfrey P, Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: (suppl 3): S112-9.
2. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-64.
3. Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990; 38: 931-6.
4. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-83.
5. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-21.
6. Schwartz U, Buzello M, Ritz E, et al. Morpholgy of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-23.
7. Ketteler M, Vermeer C, Wanner C, Westenfeld R, Jahnen-Dechent W, Floege J. Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Blood Purif 2002; 20: 473-6.
8. Moe SM, O'Neill K, Duan D, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638-47.
9. Shanahan C, Cary NRB, Salisbury J, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis. Evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-76.
10. Elliot J. Studies in inorganic chemistry. Structure and chemistry of the apatites and other calcium ortophosphates. Amsterdam: Elsevier, 1994.
11. Schmid K, McSharry WO, Pameijer CH, Binette JP. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 1980; 37: 199-210.
12. Dmitrovsky E, Boskey A. Calcium-acidic phospholipid-phosphate complexes in human atherosclerotic aortas. Calcif Tissue Int 1985; 37: 121-5.
13. Becker A, Epple M, Muller KM, Schmitz I. A comparative study of clinically well characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods. J Inorg Biochem 2004; 98: 2032-8.
14. Baeuerlein EE. Biomineralization: progress in biology, molecular biology and application. Weinheim: Wiley-VCH, 2004.
15. Mann S. Biomineralization: principles and concepts in bioinorganic materials chemistry. Oxford: Oxford University Press, 2001.
16. Block GA, Port F. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for change in management. Am J Kidney Dis 2000; 35: 1226-37.
17. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-17.
18. Reynolds JL, Joanides AJ, Skeppert JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-67.
19. Olsson L-F, Odselius R, Ribbe E, Hegbrant J. Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas. Am J Kidney Dis 2001; 38: 377-83.
20. Epple M, Lanzer P. How much interdisciplinarity is required to understand vascular calcifications? Formulation of four basic principles of vascular calcification. Z Kardiol 2001; 90: (suppl 3): S2-5.
21. Sandin K, Kloo L, Odselius R, Olsson L-F. The observation of amorphous calcium phosphate precipitates in a simple supersaturated inorganic blood serum model - composition and morphology. Biomaterials (submitted for publication).
22. Bjerrum N. Investigations on the solubility of calcium phosphates. Nordic (19th Scandinavian) scientist meeting in Helsingfors 1936; 344-8; Selected papers, Copenhagen, 1949; 245-8.
23. Kratz A, Lewandrowski KB. Normal reference laboratory values. N Engl J Med 1998; 339: 1063-7.
24. Lentner C ed. Geigy Scientific Tables 3. Basel: Ciba-Geigy, 1984.
25. Clase CM, Norman GL, Beecroft ML, Churchill DN. Albumin-corrected calcium and ionized calcium in stable hemodialysis patients. Nephrol Dial Transplant 2000; 15: 1841-6.
26. Stability Constants Database IUPAC, Academic software 2001.
27. Lundager Madsen HE. Ionic concentrations in calcium phosphate solutions. II. The solubility of hydroxylapatite in water or salt solutions. Acta Chem Scand 1975; A 29: 745-8.
28. Tung MS, Eidelman N, Sieck B, Brown WE. Octacaclium phosphate solubility product from 4 to 37°C. J Res Natl Bur Stand 1988; 93: 613-24.
29. Jahnen-Dechent W, Schinke T, Trindl A, et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997; 272: 31496-503.
30. Luo G, Ducy P, McKee M, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
31. 2-Heremans-Schimd glycoprotein/fetuin-A is a systematically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-66.
32. Xie J, Riley C, Kumar M, Chittur K. FTIR/ATR study of protein adsorption and brushite transformation to hydroxyapatite. Biomaterials 2002; 23: 3609-16.
33. Alfrey AC, Solomons C, Ciricillo J, Miller N. Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia. J Clin Invest 1976; 57: 692-9.
34. European best practice guidelines for haemodialysis (part 1). Nephrol Dial Transplant 2002; 17 (suppl 7): XX.
35. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (suppl 3): S1-20.
36. Kim S, Goldstein M, Szabo T, Pierratos A. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003; 41: E12.
37. Russel R, Brookshire M, Zekonis M, Moe S. Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca × P product and aggressive wound care. Clin Nephrol 2002; 58: 238-43.
38. Tomazic B. Physicochemical principles of cardiovascular calcification. Z Kardiol 2001; 90: (suppl 3): S68-S80.